XNK Therapeutics

0 followers


XNK Therapeutics is focused on realizing the potential in autologous NK cell therapies for cancer patients.

Industries

Headquarters

Employees

Links

Org chart

Johan Liwing
Chief Executive Officer

Johan Liwing

Collapse
Hans Ericson
Chief Financial Officer
Stephan Meinke
Head of R&D
Michael Uhlin
Chief Scientific Officer
Anna-Karin Maltais (formerly Roos)
Chief Scientific Officer
Julia Remnestål
Regulatory Affairs Manager
Linda Brink
Head Of Quality
Markus Thor
Chief Business Officer
Paul Do
Head of Clinical Manufacturing and Engineering
Per-Henrik Holmqvist, PhD
Platform Development Lead
Peter Hovstadius M.D., Ph.D.
Chief Medical Officer
Zahra Rajabkhani
Production Lead
Hugo Petit
Chief Financial Officer